RWLK - ReWalk Robotics Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3201
+0.0192 (+6.38%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close 0.3009
Open 0.3050
Bid 0.3160 x 900
Ask 0.3240 x 900
Day's Range 0.3050 - 0.3282
52 Week Range 0.1610 - 1.3500
Volume 4,317,623
Avg. Volume 6,277,827
Market Cap 23.397M
Beta (3Y Monthly) 2.47
PE Ratio (TTM) N/A
EPS (TTM) -0.5890
Earnings Date Mar 6, 2019 - Mar 11, 2019
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 1.75
Trade prices are not sourced from all markets
  • ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices
    PR Newswire 3 days ago

    ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 13, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), disclosed today that Cigna Corporation, a leading global health service company, has revised its policy regarding coverage of exoskeleton medical devices for persons with spinal cord injury (SCI). Cigna, which previously had a non-coverage policy, will now review submissions from beneficiaries on a case-by-case basis to consider providing coverage based on medical criteria. This policy revision is the first of its kind by a major private insurer for individuals eligible to use exoskeleton devices.

  • Thomson Reuters StreetEvents 4 days ago

    Edited Transcript of RWLK earnings conference call or presentation 8-Feb-19 1:30pm GMT

    Q4 2018 Rewalk Robotics Ltd Earnings Call

  • Associated Press 8 days ago

    ReWalk: 4Q Earnings Snapshot

    The Yokneam Ilit, Israel-based company said it had a loss of 10 cents per share. The maker of wearable robotic exoskeletons that help paralyzed patients walk posted revenue of $1.6 million in the period. ...

  • GlobeNewswire 8 days ago

    ReWalk Robotics Reports Fourth Quarter 2018 Financial Results

    — 2018 total revenue of $6.5 million and $1.6 million during the fourth quarter of 2018 —— Preparing for 2019 commercial launch of ReStore for stroke patients — YOKNEAM ILIT,.

  • Have Insiders Been Buying ReWalk Robotics Ltd. (NASDAQ:RWLK) Shares?
    Simply Wall St. 10 days ago

    Have Insiders Been Buying ReWalk Robotics Ltd. (NASDAQ:RWLK) Shares?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We've lost count of how many times Read More...

  • GlobeNewswire 11 days ago

    ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 05, 2019 -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its.

  • ACCESSWIRE 22 days ago

    Watch These 4 Healthcare Stocks Set the Pace on Friday (1/25/19)

    Companies in the healthcare industry have recognized that, as medical experts discover more diseases and ailments, this creates an opportunity to invest in products/services to improve the quality of life for patients. Premier Health Group (OTC:PHGRF) (CSE:PHGI), vTv Therapeutics Inc (VTVT), Canopy Growth Corp (CGC) (WEED.TO), and Rewalk Robotics Ltd (RWLK) represent four healthcare companies determined to invest in the betterment of healthcare. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company focused on developing nuanced approaches that combine human skill-based expertise with up and coming technologies for the healthcare industry to create optimal care solutions for their patients.

  • ACCESSWIRE last month

    Best Bottom Bouncing Opportunities

    HENDERSON, NV / ACCESSWIRE / January 17, 2019 / Below are some incredible opportunities in the market today. Gopher Protocol Inc. (GOPH) , is an absolutely fascinating company that was trading has a 52-week ...

  • GlobeNewswire last month

    ReWalk Announces Preliminary Fiscal Year 2018 Revenue

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced preliminary, unaudited revenue for the fiscal year ended December 31, 2018. On a preliminary basis, based on the information currently available, for the fiscal year ended December 31, 2018, the Company expects that total revenue for the year will be approximately $6.5 million. With our clinical study accrual now completed, we plan to finalize our ReStore submission to the U.S Food and Drug Administration shortly,” said Larry Jasinski, Chief Executive Officer of ReWalk.

  • Our Take On ReWalk Robotics Ltd.’s (NASDAQ:RWLK) CEO Salary
    Simply Wall St. 2 months ago

    Our Take On ReWalk Robotics Ltd.’s (NASDAQ:RWLK) CEO Salary

    Larry Jasinski has been the CEO of ReWalk Robotics Ltd. (NASDAQ:RWLK) since 2012. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...

  • Thomson Reuters StreetEvents 2 months ago

    Edited Transcript of RWLK earnings conference call or presentation 8-Nov-18 9:30pm GMT

    Q3 2018 Rewalk Robotics Ltd Earnings Call

  • ACCESSWIRE 2 months ago

    ReWalk Robotics Is Moving Forward with New Funding, Analysts Review and Company Guidance

    NEW YORK, NY / ACCESSWIRE / December 12, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on ReWalk Robotics, Ltd. (RWLK), a company that develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk recently announced a new funding program and will receive aggregate gross proceeds of approximately $12.1 million from the offering. ReWalk intends to use the net proceeds from the offering for sales, marketing and reimbursement expenses related to market development activities and broadening third-party payor coverage, research and development costs related to developing its lightweight ''soft suit'' exoskeleton technology for various lower limb disabilities, including stroke and other indications affecting the ability to walk, and the repayment of certain outstanding indebtedness.

  • Huawei's CFO arrested after allegedly breaking Iran sanctions
    Yahoo Finance 2 months ago

    Huawei's CFO arrested after allegedly breaking Iran sanctions

    Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:00 a.m. ET.

  • GlobeNewswire 3 months ago

    Report: Developing Opportunities within ReWalk Robotics, ImmuCell, SCYNEXIS, Fuel Tech, Garrison Capital, and AMREP — Future Expectations, Projections Moving into 2018

    NEW YORK, Nov. 23, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • United Spinal Association Issues Recommendation for Insurers to Consider Powered Exoskeleton Devices Medically Necessary for Paralyzed Individuals
    PR Newswire 3 months ago

    United Spinal Association Issues Recommendation for Insurers to Consider Powered Exoskeleton Devices Medically Necessary for Paralyzed Individuals

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 15, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company") applauds United Spinal Association's recommendation, dated November 9, 2018, that health insurance providers consider the use of powered exoskeleton devices as medically necessary for eligible individuals with spinal cord injuries (SCI) in both the institutional and home settings who meet the applicable Food and Drug Administration (FDA) indications for use. According to United Spinal Association, exoskeletons have the potential to enable more than 40% of the SCI population to resume ambulation, which can lead to a healthier and improved quality of life, and the benefits of increased physical activity translate into improvements in health outcomes and decreased utilization of high healthcare costs.

  • ReWalk Announces Placement of 500th Exoskeleton System
    PR Newswire 3 months ago

    ReWalk Announces Placement of 500th Exoskeleton System

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 9, 2018 /PRNewswire/ -- ReWalk Robotics Ltd. (RWLK) ("ReWalk" or the "Company") announced today that the company has placed its 500th robotic exoskeleton medical device. The majority of these devices are personal systems used by individuals with spinal cord injury in their homes and communities, while others are located in rehabilitation centers to evaluate and train potential new device owners. To continue its growth, the Company is focused on expanding insurance coverage of exoskeletons for all persons with spinal cord injury and has helped develop national coverage policies with payers in several countries, including Germany, Italy and the U.S. Department of Veterans Affairs in the U.S.

  • ReWalk Robotics (RWLK) Reports Q3 Loss, Misses Revenue Estimates
    Zacks 3 months ago

    ReWalk Robotics (RWLK) Reports Q3 Loss, Misses Revenue Estimates

    ReWalk (RWLK) delivered earnings and revenue surprises of 13.33% and -23.73%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press 3 months ago

    ReWalk: 3Q Earnings Snapshot

    On a per-share basis, the Yokneam Ilit, Israel-based company said it had a loss of 13 cents. The maker of wearable robotic exoskeletons that help paralyzed patients walk posted revenue of $1.6 million ...

  • Simply Wall St. 5 months ago

    Do You Know Who Else Invests In ReWalk Robotics Ltd (NASDAQ:RWLK)?

    A look at the shareholders of ReWalk Robotics Ltd (NASDAQ:RWLK) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, Read More...

  • Thomson Reuters StreetEvents 6 months ago

    Edited Transcript of RWLK earnings conference call or presentation 14-Aug-18 12:30pm GMT

    Q2 2018 Rewalk Robotics Ltd Earnings Call

  • PR Newswire 6 months ago

    ReWalk Robotics (RWLK) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

    BOSTON , Aug. 28, 2018 /PRNewswire/ -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, is investigating whether ReWalk Robotics ("ReWalk" ...